Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Yoshiyuki Hiraki"'
Autor:
Masahiko Toyota, Yoshifumi Oku, Takashi Yoshiura, Hidetaka Arimura, Yasumasa Saigo, Hideki Hirata, Tran Thi Thao Nguyen, Yoshiyuki Hiraki
Publikováno v:
Journal of Radiation Research
This study investigates whether in-room computed tomography (CT)-based adaptive treatment planning (ATP) is robust against interfractional location variations, namely, interfractional organ motions and/or applicator displacements, in 3D intracavitary
Autor:
Yoko Harima, Takayuki Ohguri, Hiromi Terashima, Tatsuya Ohno, Koh Tuji, Hajime Imada, Masahiro Tanaka, Yoshiyuki Hiraki, Hideyuki Sakurai
Publikováno v:
International Journal of Hyperthermia. 32:801-808
Purpose: To evaluate the effectiveness of whole-pelvic hyperthermia (HT) added to standard chemoradiotherapy (CRT) in locally advanced cervical cancer (CC), by investigating the clinical response and survival of patients treated with cisplatin-based
Autor:
R. Hanaya, Hiroyuki Uchida, Hirofumi Hirano, Mika Habu, Sei Sugata, Kazutaka Yatsushiro, Yoshiyuki Hiraki, Yuriz Bakhtiar, Tatsuki Oyoshi, Shingo Fujio, Hiroshi Tokimura, Shunji Yunoue, Hitoshi Yamahata, Hiroto Kawano, Mikio Ogita, Kazunori Arita, Hajime Yonezawa
Publikováno v:
British Journal of Neurosurgery. 29:206-212
The purpose of this study is to elucidate the trend of glioblastoma outcome and scrutinize the factors contributing to better outcome over three decades.Survival time and the influencing factors were retrospectively analyzed in 223 newly diagnosed pr
Autor:
Itaru Omoto, Shoji Natsugoe, Daisuke Matsushita, Sumiya Ishigami, Takaaki Arigami, Tetsuhiro Owaki, Hiroshi Okumura, Yoshiaki Kita, Yoshiyuki Hiraki, Ken Sasaki, Yoshikazu Uenosono, Yasuto Uchikado
Publikováno v:
Annals of Surgical Oncology. 21:2845-2849
The prognosis of patients with esophageal squamous-cell cancer (ESCC) and multiple lymph-node metastases is quite poor. We examined whether neoadjuvant chemoradiation therapy (CRT) has a beneficial effect in such patients. A total of 50 consecutive p
Autor:
Hiroshi Okumura, Bunpei Nabeki, Sumiya Ishigami, Daisuke Matsushita, Masayuki Nakajo, Tetsuhiro Owaki, Tetsuro Setoyama, Masataka Matsumoto, Yoshiaki Kita, Yoshiyuki Hiraki, Yasuto Uchikado, Itaru Omoto, Ken Sasaki, Shoji Natsugoe, Toshihide Sakurai
Publikováno v:
International Journal of Clinical Oncology. 18:329-334
Definitive evaluation of surgical specimens obtained after neoadjuvant chemoradiation therapy (CRT) is important for assessing additional treatment or prognosis in patients with esophageal squamous cell carcinoma (ESCC). In this study, we examined th
Autor:
Yuko Mataki, Sonshin Takao, Yoshiyuki Hiraki, Hiroyuki Shinchi, Hiroshi Kurahara, Shinichi Ueno, Masahiko Sakoda, Kosei Maemura, Masayuki Nakajo, Shoji Natsugoe
Publikováno v:
Journal of Hepato-Biliary-Pancreatic Sciences. 19:152-158
S-1 is a new oral fluoropyrimidine anticancer agent shown to be effective for pancreatic cancer. In a previous phase I trial, we evaluated the safety of S-1 combined with radiotherapy to determine the maximum tolerated dose and dose-limiting toxicity
Autor:
Seiji Ono, Yoshiyuki Hiraki, Toshiya Maebayashi, Tsutomu Saito, Hajime Imada, Tomoya Saito, Yoshiaki Tanaka
Publikováno v:
Thermal Medicine. 23:1-10
Clinical research in hyperthermic oncology began in 1978, when the research group chaired by Prof. T. Sugahara, supported by a grant from the Ministry of Education, played an important part. Six years later, the first annual meeting of the Japanese S
Autor:
Hiroshi, Kurahara, Hiroyuki, Shinchi, Kosei, Maemura, Yuko, Mataki, Masahiko, Sakoda, Satoshi, Iino, Shinichi, Ueno, Yoshiyuki, Hiraki, Sonshin, Takao, Shoji, Natsugoe
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(3)
A 5 5-year-old woman was admitted to our hospital for pancreatic cancer with liver metastasis. We performed pancreatoduodenectomy, D2 dissection, and partial liver resection. Tissue from a resected liver metastasis was submitted to a chemosensitivity
Autor:
Kosei, Maemura, Hiroyuki, Shinchi, Hidetoshi, Noma, Yuko, Mataki, Hiroshi, Kurahara, Shinichi, Maeda, Yoshiyuki, Hiraki, Masayuki, Nakajo, Shoji, Natsugoe, Sonshin, Takao
Publikováno v:
Anticancer research. 28(4C)
Concurrent chemoradiotherapy with gemcitabine improves median survival for patients with unresectable pancreatic cancer. Recently, hyperfractionated accelerated radiotherapy (HART) has been used to treat these patients; however, the safety and effica
Autor:
Masaoki Makino, Sunao Tokumaru, Yoshiyuki Shioyama, Yoshiyuki Hiraki, Kenichi Jingu, Takafumi Toita, Nobuyuki Hayashi, Hiromi Terashima, Naofumi Hayabuchi, Natsuo Oya, Hiroaki Suefuji, Katsumasa Nakamura, Kazuo Kusuhara
Publikováno v:
Japanese journal of clinical oncology. 38(4)
Background: We investigated the interobserver variation in the prostate target volume and the trend toward the use of diagnostic computed tomography (CT) or magnetic resonance (MR) images for treatment planning. Methods: Twenty-five radiation oncolog